News
Ajanta Pharma's Paithan unit concludes USFDA inspection
22-Apr-2026 | 09:22
With 5 observations under Form - 483
Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.
